23-008522 nhlbi requires variantplex reagents for sequencing in order to analyze mutations of myeloid cells.
Ended Purchase Order Awarded Last action
- Contract number
- 75N92023P00154
- Awardee
-
Archerdx LLC UEI NAG7RNTJQ5T8 Part of Invitae Corporation
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- ] VariantPlex® NHLBI Research Myeloid, for Illumina® - 8 Reactions Solicitation · NHLBI23008522 · Posted Mar 28, 2023
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80301, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$15,650 | |
| Original award | $15,650 |
Quick answers
Who was awarded contract 75N92023P00154?
75N92023P00154 was awarded to Archerdx LLC by National Heart Lung and Blood Institute (National Institutes of Health) on April 13, 2023.
How much is contract 75N92023P00154 worth?
The government has obligated $0 on 75N92023P00154.
Was contract 75N92023P00154 competed?
The extent of competition for 75N92023P00154 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award